BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 17486613)

  • 1. [123I] FP-CIT spect study in vascular parkinsonism and Parkinson's disease.
    Zijlmans J; Evans A; Fontes F; Katzenschlager R; Gacinovic S; Lees AJ; Costa D
    Mov Disord; 2007 Jul; 22(9):1278-85. PubMed ID: 17486613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism.
    Lorberboym M; Djaldetti R; Melamed E; Sadeh M; Lampl Y
    J Nucl Med; 2004 Oct; 45(10):1688-93. PubMed ID: 15471834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and 123I-FP-CIT SPECT imaging in vascular parkinsonism and Parkinson's disease.
    Benítez-Rivero S; Marín-Oyaga VA; García-Solís D; Huertas-Fernández I; García-Gómez FJ; Jesús S; Cáceres MT; Carrillo F; Ortiz AM; Carballo M; Mir P
    J Neurol Neurosurg Psychiatry; 2013 Feb; 84(2):122-9. PubMed ID: 22906618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 123I-MIBG cardiac uptake, smell identification and 123I-FP-CIT SPECT in the differential diagnosis between vascular parkinsonism and Parkinson's disease.
    Navarro-Otano J; Gaig C; Muxi A; Lomeña F; Compta Y; Buongiorno MT; Martí MJ; Tolosa E; Valldeoriola F
    Parkinsonism Relat Disord; 2014 Feb; 20(2):192-7. PubMed ID: 24252299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [123I]beta-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease.
    Gerschlager W; Bencsits G; Pirker W; Bloem BR; Asenbaum S; Prayer D; Zijlmans JC; Hoffmann M; Brücke T
    Mov Disord; 2002 May; 17(3):518-23. PubMed ID: 12112200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precise Evaluation of Striatal Oxidative Stress Corrected for Severity of Dopaminergic Neuronal Degeneration in Patients with Parkinson's Disease: A Study with 62Cu-ATSM PET and 123I-FP-CIT SPECT.
    Neishi H; Ikawa M; Okazawa H; Tsujikawa T; Arishima H; Kikuta KI; Yoneda M
    Eur Neurol; 2017; 78(3-4):161-168. PubMed ID: 28848099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine learning models for the differential diagnosis of vascular parkinsonism and Parkinson's disease using [(123)I]FP-CIT SPECT.
    Huertas-Fernández I; García-Gómez FJ; García-Solís D; Benítez-Rivero S; Marín-Oyaga VA; Jesús S; Cáceres-Redondo MT; Lojo JA; Martín-Rodríguez JF; Carrillo F; Mir P
    Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):112-9. PubMed ID: 25120041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
    Tissingh G; Booij J; Bergmans P; Winogrodzka A; Janssen AG; van Royen EA; Stoof JC; Wolters EC
    J Nucl Med; 1998 Jul; 39(7):1143-8. PubMed ID: 9669384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report.
    Di Giuda D; Calcagni ML; Totaro M; Cocciolillo F; Piano C; Soleti F; Fasano A; Cioni B; Bentivoglio AR; Giordano A
    Nucl Med Commun; 2012 Sep; 33(9):933-40. PubMed ID: 22735298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in nigro-striatal impairment in clinical variants of early Parkinson's disease: evidence from a FP-CIT SPECT study.
    Rossi C; Frosini D; Volterrani D; De Feo P; Unti E; Nicoletti V; Kiferle L; Bonuccelli U; Ceravolo R
    Eur J Neurol; 2010 Apr; 17(4):626-30. PubMed ID: 20050904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential diagnosis of Parkinson's disease and vascular parkinsonism by (99m)Tc-TRODAT-1.
    Tzen KY; Lu CS; Yen TC; Wey SP; Ting G
    J Nucl Med; 2001 Mar; 42(3):408-13. PubMed ID: 11337515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.
    Booij J; Habraken JB; Bergmans P; Tissingh G; Winogrodzka A; Wolters EC; Janssen AG; Stoof JC; van Royen EA
    J Nucl Med; 1998 Nov; 39(11):1879-84. PubMed ID: 9829575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline [(123) I]FP-CIT SPECT (DaTSCAN) severity correlates with medication use at 3 years in Parkinson's disease.
    Nissen T; Malek N; Grosset KA; Newman EJ; Patterson J; Hadley D; Grosset DG
    Acta Neurol Scand; 2014 Mar; 129(3):204-8. PubMed ID: 23962145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease.
    Lorberboym M; Treves TA; Melamed E; Lampl Y; Hellmann M; Djaldetti R
    Mov Disord; 2006 Apr; 21(4):510-4. PubMed ID: 16250023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preserved Extrastriatal
    Nicastro N; Burkhard PR; Garibotto V
    Mol Imaging Biol; 2020 Dec; 22(6):1592-1599. PubMed ID: 32468408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single photon emission computed tomography striatal asymmetry index may predict dopaminergic responsiveness in Parkinson disease.
    Contrafatto D; Mostile G; Nicoletti A; Raciti L; Luca A; Dibilio V; Lanzafame S; Distefano A; Drago F; Zappia M
    Clin Neuropharmacol; 2011; 34(2):71-3. PubMed ID: 21406999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [(123) I]FP-CIT-SPECT asymmetry index to differentiate Parkinson's disease from vascular parkinsonism.
    Contrafatto D; Mostile G; Nicoletti A; Dibilio V; Raciti L; Lanzafame S; Luca A; Distefano A; Zappia M
    Acta Neurol Scand; 2012 Jul; 126(1):12-6. PubMed ID: 21916850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between striatal
    Sawada H; Orimo S
    Rinsho Shinkeigaku; 2019 Dec; 59(12):799-805. PubMed ID: 31761832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Akinetic-rigid and tremor-dominant Parkinson's disease patients show different patterns of FP-CIT single photon emission computed tomography.
    Eggers C; Kahraman D; Fink GR; Schmidt M; Timmermann L
    Mov Disord; 2011 Feb; 26(3):416-23. PubMed ID: 21264942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are Dopa-responsive dystonia and Parkinson's disease related disorders? A case report.
    Eggers C; Volk AE; Kahraman D; Fink GR; Leube B; Schmidt M; Timmermann L
    Parkinsonism Relat Disord; 2012 Jun; 18(5):666-8. PubMed ID: 22030322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.